Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Columbus, Ohio


Purpose:

The purpose of this study is to determine if the drug motexafin gadolinium will be an effective treatment for patients who have chronic lymphocytic leukemia (CLL) that has come back after treatment or that has stopped responding to treatment.


Criteria:

Inclusion Criteria: - At least 18 years old - Refractory or relapsed CLL - ECOG performance status score of 0, 1, or 2 - Each patient must sign a study-specific informed consent form Exclusion Criteria: Laboratory values of: - Platelet count <30,000/uL - AST or ALT >2 x the upper limit of normal (ULN) - Total bilirubin >2 x ULN - Creatinine >2.0 mg/dL - Chemotherapy, radiation therapy, immunotherapy, systemic corticosteroids, or systemic biologic anticancer therapy within 21 days before beginning study treatment - Women who are pregnant or lactating


NCT ID:

NCT00076401


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Columbus, Ohio
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: December 10, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.